About the role
MUST LIVE IN THE BAY AREA TO APPLY
NOTE: THIS IS POSITION IS UNPAID, EDUCATIONAL, & FOR TRAINING - EQUITY COMP AND A TRAVEL STIPEND WILL BE PROVIDED
Role
As a Research Intern at Nanotrace, you will play a role in supporting projects critical to the development of our nanoparticle technology. Initially, you'll be working with nanoparticles in mammalian cell-based models and antibody-based assays (immunohistochemistry IHC, immunocytochemistry, flow cytometry, etc.). Protein engineering experience is a plus.
What We're Looking For (Qualifications)
Education
- Bachelor's or Master's degree in Bioengineering, Biochemistry, Chemistry, or a related field.
- Proficiency in pipetting and preparing accurate dilutions.
- Must have a solid understanding of synthetic organic chemistry and be capable of conducting common organic reactions and bioconjugations (e.g. NHS-ester labeling, copper-free click chemistry).
- Familiarity with automated oligonucleotide synthesis is a strong plus.
Research Experience
- Prior laboratory experience in biochemistry or bioengineering, either in academic or industry settings.
- Most preferably, the candidate has hands-on experience with small-scale bench chemistry as well.
Soft Skills
- Ability to work in a fast-paced, collaborative environment, and to communicate scientific findings effectively.
Details
- Schedule: Full-time, Monday to Friday
- Period of Internship: 1 year or longer (only apply if you can commit to this)
- Location: Lab based in San Francisco, Dogpatch area
- Equity: you will be granted an stock option grant which will vest in monthly increments for the period of time you are with us.
- Stipend: Nanotrace within budget will cover your travel costs (Bart, Muni, Car, etc) to and from our offices.
Why Join Us?
- Be part of an innovative startup working at the forefront of nanomedicine.
- Work next to some of the most brilliant minds in chemistry and nanomedicine.
- Gain hands-on experience in advanced nanoparticle research and biotechnology.
- Work alongside a team of experienced scientists dedicated to solving complex biological and chemical challenges.
- Potentially change the world with revolutionary diagnostic and therapeutic technology to treat cancer and genetic disorders.
About Nanotrace, Inc.
Nanotrace, Inc. is a biotech startup based in San Francisco. We are pioneering a breakthrough nanoparticle delivery technology designed to carry out pre-programmed functions within cells, namely detecting cancer biomarkers and delivering therapeutic drugs. Our mission is to validate this cutting-edge approach in animal models, operating in a fast-paced, high-risk, high-reward environment. As a small and agile team with decades of combined scientific expertise, we move quickly to generate results and overcome challenges.
Nanotrace is founded by Dr. Will Briley, PhD Molecular Biology from Northwestern; Dr. Paul Weiss, renowned nanoscientist, distinguished UCLA professor, and a UC Presidential Chair (wikipedia); David Spector, an experienced founder and formerly a Partner at Sequoia Capital, Google, and MIT; and, Chief Medical Advisor, Dr. Krishna Komanduri, Department Chief & Head of Hematology & Oncology, UCSF, and Clinical Director of the UCSF Living Therapeutics Initiative. Scientific advisory board (SAB) and partners include experts from MIT, Harvard, UCLA, Columbia, Memorial Sloan Kettering, ZEISS microscopy, and The Langer Lab.